NCT06690892 Investigating the Effects of Beef Consumption on Cognitive and Brain Health
| NCT ID | NCT06690892 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nebraska Lincoln |
| Condition | Dietary Intervention |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2025-09-22 |
| Primary Completion | 2026-09 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The goal of this clinical trial is to learn if eating more beef will lead to better cognition and a healthier brain in younger adults. The main questions it aims to answer are: * Does eating more beef lead to higher scores on cognitive tests and better quality of life? * Does eating more beef lead to better brain function? Researchers will compare participants in the experimental group (participants who will eat 25 ounces of beef every week during the dietary intervention) to control participants (participants who will eat 5 ounces of beef every week during the dietary intervention). Participants will: * Be instructed to prepare and consume ready-to-eat beef meals along with their regular diet and not eat any more beef other than what they are given * Visit the study facilities once every week to pick up ready-to-eat beef meals; and complete a brief survey every week to track their consumption of the provided beef meals, and a dietary survey every 4 weeks * Visit the study facilities before and after the 12-week of intervention period for researchers to study them
Eligibility Criteria
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study * Males and females; Age 19-24 * Willingness to adhere to the ready-to-eat beef intervention regimen * Enrolled at University of Nebraska-Lincoln * BMI between 18.5 and 39.9 * Not pregnant or nursing * No history of cognitive or metabolic diseases indicated by diagnosis, including neurodegenerative disease, stroke, Type 1 and 2 diabetes, metabolic syndrome, cardiovascular disease, liver disease, kidney disease, and cancer * No history of eating or anxiety disorders * Willing to discontinue dietary supplement use throughout the duration of the study, if they are consuming supplement at the time of the registration * No known contraindication to MRI scans as determined by the MRI screening survey questions Exclusion Criteria: * Current use of medications that may affect their response